 |
 |
Phytopharm Announces Commencement of Phase II Study of Cogane in Patients with ... PharmaLive (press release) (subscription) Dr. Warren Olanow, one of the Co-Chief Investigators for the study and a member of Phytopharm's scientific advisory panel on Parkinson's disease (PD) ... great news! this is a promising treatment -- and is suppposed to be neuroprotective. And no brain surgery! the cliinicaltrials.gov record, not yet updated is at http://clinicaltrials.gov/ct2/show/NCT01060878?term=pym50028&rank=1 under PYM50028 They are looking for newly diagnosed patiets for the clinical trial , and those not yet on PD medicine. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn